{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T17:18:34Z","timestamp":1709399914206},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T00:00:00Z","timestamp":1379030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s12032-013-0722-5","type":"journal-article","created":{"date-parts":[[2013,9,12]],"date-time":"2013-09-12T07:33:28Z","timestamp":1378971208000},"source":"Crossref","is-referenced-by-count":6,"title":["Orbital and ocular adnexal Mucosa-Associated Lymphoid Tissue (MALT) lymphomas: a single-center 10-year experience"],"prefix":"10.1007","volume":"30","author":[{"given":"M.","family":"Smiljanic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Milosevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Antic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Andjelic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Djurasinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Todorovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bogdanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mihaljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,13]]},"reference":[{"issue":"5","key":"722_CR1","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood-2006-02-005017","volume":"108","author":"D Decaudin","year":"2006","unstructured":"Decaudin D, de Cremoux P, Vincent-Salomon A, Dendale R, Rouic LL, et al. Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood. 2006;108(5):1451\u201360.","journal-title":"Blood"},{"key":"722_CR2","doi-asserted-by":"crossref","DOI":"10.1007\/b138583","volume-title":"Orbital tumors: diagnosis and treatment","author":"Zeynel A Karcioglu","year":"2005","unstructured":"Karcioglu Zeynel A. Orbital tumors: diagnosis and treatment. New York: Springer; 2005."},{"issue":"13","key":"722_CR3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/djj248","volume":"98","author":"R Moslehi","year":"2006","unstructured":"Moslehi R, Devesa SS, Schairer C, Fraumeni JF Jr. Rapidly increasing incidence of ocular non-Hodgkin lymphoma. J Natl Cancer Inst. 2006;98(13):936\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"722_CR4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/annonc\/mdm513","volume":"19","author":"AJ Ferreri","year":"2008","unstructured":"Ferreri AJ, Dolcetti R, Du MQ, Doqlioni C, Resti AG, et al. Ocular adnexal MALT Lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol. 2008;19(5):835\u201346.","journal-title":"Ann Oncol"},{"issue":"2","key":"722_CR5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood-2005-06-2332","volume":"107","author":"MF Rosado","year":"2005","unstructured":"Rosado MF, Byrne JG, Ding F, et al. Ocular adnexal lymphoma: a clinicopathological study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood. 2005;107(2):467\u201372.","journal-title":"Blood"},{"issue":"6","key":"722_CR6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.eye.6702027","volume":"20","author":"CM Nutting","year":"2006","unstructured":"Nutting CM, Shah-Desai S, Rose GE, Norton AP, Plowman PN. Thyroid orbitopathy possibly predisposes to late-onset of periocular lymphoma. Eye. 2006;20(6):645\u20138.","journal-title":"Eye"},{"issue":"17","key":"722_CR7","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","volume":"343","author":"AP Weetman","year":"2000","unstructured":"Weetman AP. Graves\u2019 disease. N Engl J Med. 2000;343(17):1236\u201348.","journal-title":"N Engl J Med"},{"issue":"8","key":"722_CR8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","volume":"96","author":"AJ Ferreri","year":"2004","unstructured":"Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell\u2019Oro S, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 2004;96(8):586\u201394.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"722_CR9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.1984","volume":"209","author":"E Chanudet","year":"2006","unstructured":"Chanudet E, Zhou Y, Bacon CM, Wotherspoon AC, M\u00fcller-Hermelink HK, et al. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J Pathol. 2006;209(3):344\u201351.","journal-title":"J Pathol"},{"issue":"2","key":"722_CR10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2141.2008.07112.x","volume":"142","author":"JM Matthews","year":"2008","unstructured":"Matthews JM, Moreno LI, Dennis J, Byrne GE Jr, Ruiz P, et al. Ocular adnexal lymphoma: no evidence for bacterial DNA associated with lymphoma pathogenesis. Br J Haematol. 2008;142(2):246\u20139.","journal-title":"Br J Haematol"},{"issue":"4","key":"722_CR11","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/bjo.2007.132316","volume":"92","author":"SB Lee","year":"2008","unstructured":"Lee SB, Yang JW, Kim CS. The association between conjunctival MALT lymphoma and Helicobacter pylori. Br J Ophthalmol. 2008;92(4):534\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"722_CR12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ophtha.2006.09.020","volume":"114","author":"NC Sj\u00f6","year":"2007","unstructured":"Sj\u00f6 NC, Foegh P, Juhl BR, Nilsson HO, Prause JU, et al. Role of Helicobacter pylori in conjunctival mucosa-associated lymphoid tissue lymphoma. Ophthalmology. 2007;114(1):182\u20136.","journal-title":"Ophthalmology"},{"issue":"3","key":"722_CR13","first-page":"328","volume":"45","author":"M Nola","year":"2004","unstructured":"Nola M, Lukenda A, Bollman M, Kalauz M, Petrovecki M, et al. Outcome and prognostic factor in ocular adnexal lymphoma. Croat Med J. 2004;45(3):328\u201332.","journal-title":"Croat Med J"},{"issue":"3","key":"722_CR14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.humpath.2006.09.007","volume":"38","author":"G Schiby","year":"2007","unstructured":"Schiby G, Polak-Charcon S, Mardoukh C, Rosenblatt K, Goldberg I, et al. Orbital marginal zone lymphomas: an immunohistochemical, polymerase chain reaction, and fluorescence in situ hybridization study. Hum Pathol. 2007;38(3):435\u201342.","journal-title":"Hum Pathol"},{"issue":"3","key":"722_CR15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","volume":"114","author":"A Stefanovic","year":"2009","unstructured":"Stefanovic A, Lossos IS. Extranodal marginal zone lymphoma of the ocular adnexa. Blood. 2009;114(3):501\u201310.","journal-title":"Blood"},{"issue":"6","key":"722_CR16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1442-9071.2001.d01-18.x","volume":"29","author":"PA McKelvie","year":"2001","unstructured":"McKelvie PA, McNab A, Francis IC, Fox R, O\u2019Day J. Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Experiment Ophthalmol. 2001;29(6):387\u201393.","journal-title":"Clin Experiment Ophthalmol"},{"issue":"4","key":"722_CR17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cncr.11539","volume":"98","author":"T Uno","year":"2003","unstructured":"Uno T, Isobe K, Shikama N, Nishikawa A, Oquchi M, et al. Radiotherapy for extranodal, marginal zone, B-cell Lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective rewiev of 50 patients. Cancer. 2003;98(4):865\u201371.","journal-title":"Cancer"},{"issue":"1","key":"722_CR18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/annonc\/mdj025","volume":"17","author":"K Tanimoto","year":"2006","unstructured":"Tanimoto K, Kaneko A, Suzuki S, Sekiquchi N, Maruayama D, et al. Long-term follow up results of no initial therapy for ocular adnexal MALT lymphoma. Ann Oncol. 2006;17(1):135\u201340.","journal-title":"Ann Oncol"},{"issue":"7","key":"722_CR19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/modpathol.3880366","volume":"14","author":"T Mannami","year":"2001","unstructured":"Mannami T, Yoshino T, Oshima K, Takase S, Kondo E, et al. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of MALT lymphoma and reactive lymphoid hyperplasia. Mod Pathol. 2001;14(7):641\u20139.","journal-title":"Mod Pathol"},{"issue":"7","key":"722_CR20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1023\/A:1008327301372","volume":"9","author":"L Baldini","year":"1998","unstructured":"Baldini L, Blini M, Guffanti A, Fossati V, Colombi M, et al. Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa. Ann Oncol. 1998;9(7):779\u201381.","journal-title":"Ann Oncol"},{"issue":"7","key":"722_CR21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ophtha.2006.01.057","volume":"113","author":"GJ Ben Simon","year":"2006","unstructured":"Ben Simon GJ, Cheung N, McKelvie P, Fox R, McNab AA. Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit. Ophthalmology. 2006;113(7):1209\u201313.","journal-title":"Ophthalmology"},{"issue":"2","key":"722_CR22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/annonc\/mdm457","volume":"19","author":"EK Song","year":"2008","unstructured":"Song EK, Kim SY, Kim TM, Lee KW, Yun T, et al. Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma. Ann Oncol. 2008;19(2):242\u20136.","journal-title":"Ann Oncol"},{"issue":"2","key":"722_CR23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.IOP.0000115594.98470.AC","volume":"20","author":"TJ Sullivan","year":"2004","unstructured":"Sullivan TJ, Grimes D, Bunce I. Monoclonal antibody treatment of orbital lymphoma. Ophthal Plast Reconstr Surg. 2004;20(2):103\u20136.","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"8","key":"722_CR24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00277-007-0301-y","volume":"86","author":"L Rigacci","year":"2007","unstructured":"Rigacci L, Nassi L, Puccioni M, Mappa S, Polito E, et al. Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas. Ann Hematol. 2007;86(8):565\u20138.","journal-title":"Ann Hematol"},{"issue":"3\u20134","key":"722_CR25","first-page":"269","volume":"9","author":"A Restrepo","year":"1998","unstructured":"Restrepo A, Raez LE, Byrne GE Jr, Johnson T, Ossi P, et al. Is central nervous system prophylaxis necessary in ocular adnexal lymphoma? Crit Rev Oncog. 1998;9(3\u20134):269\u201373.","journal-title":"Crit Rev Oncog"},{"issue":"1","key":"722_CR26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0360-3016(93)90173-S","volume":"26","author":"MC Smitt","year":"1993","unstructured":"Smitt MC, Donaldson SS. Radiotherapy is successful treatment for orbital lymphoma. Int J Radiat Oncol Biol Phys. 1993;26(1):59\u201366.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"722_CR27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.radonc.2005.11.005","volume":"78","author":"Y Ejima","year":"2006","unstructured":"Ejima Y, Sasaki R, Okamoto Y, Maruta T, Azumi A, et al. Ocular adnexal mucosa associated lymphoid tissue lymphoma treated with radiotherapy. Radiother Oncol. 2006;78(1):6\u20139.","journal-title":"Radiother Oncol"},{"issue":"5","key":"722_CR28","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0360-3016(03)00767-3","volume":"57","author":"CY Fung","year":"2003","unstructured":"Fung CY, Tarbell NJ, Lucarelli MJ, Goldberg SI, Linqqood RM, et al. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes. Int J Radiat Oncol Biol Phys. 2003;57(5):1382\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"722_CR29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0360-3016(01)02729-8","volume":"52","author":"QT Le","year":"2002","unstructured":"Le QT, Eulau SM, George TI, Hildebrand R, Warnke RA, et al. Primary radiotherapy for localized orbital MALT lymphoma. Int J Radiat Oncol Biol Phys. 2002;52(3):657\u201363.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"722_CR30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0167-8140(00)00328-5","volume":"59","author":"SL Stafford","year":"2001","unstructured":"Stafford SL, Kozelsky TF, Garrity JA, Kurtin PJ, Leavitt JA, et al. Orbital Lymphoma: radiotherapy outcome and complications. Radiother Oncol. 2001;59(2):139\u201344.","journal-title":"Radiother Oncol"},{"issue":"24","key":"722_CR31","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2011.41.4466","volume":"30","author":"AJ Ferreri","year":"2012","unstructured":"Ferreri AJ, Govi S, Pasini E, Mappa S, Bertoni F, et al. Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J Clin Oncol. 2012;30(24):2988\u201394.","journal-title":"J Clin Oncol"},{"issue":"4","key":"722_CR32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/annonc\/mdn692","volume":"20","author":"B Esmaeli","year":"2009","unstructured":"Esmaeli B, McLaughlin P, Pro B, Samaniego F, Gayed I, et al. Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalinr) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma. Ann Oncol. 2009;20(4):709\u201314.","journal-title":"Ann Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0722-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-013-0722-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0722-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:22:26Z","timestamp":1559442146000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-013-0722-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,13]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["722"],"URL":"https:\/\/doi.org\/10.1007\/s12032-013-0722-5","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,13]]},"article-number":"722"}}